- Home
- DOLE vs VRDN Comparison
DOLE vs VRDN Comparison
Compare DOLE & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOLE
- VRDN
- Stock Information
- Founded
- DOLE 1851
- VRDN 2006
- Country
- DOLE Ireland
- VRDN United States
- Employees
- DOLE N/A
- VRDN N/A
- Industry
- DOLE Farming/Seeds/Milling
- VRDN Medical Specialities
- Sector
- DOLE Consumer Staples
- VRDN Health Care
- Exchange
- DOLE Nasdaq
- VRDN Nasdaq
- Market Cap
- DOLE 1.3B
- VRDN 1.3B
- IPO Year
- DOLE 2021
- VRDN N/A
- Fundamental
- Price
- DOLE $14.25
- VRDN $14.24
- Analyst Decision
- DOLE Buy
- VRDN Strong Buy
- Analyst Count
- DOLE 3
- VRDN 11
- Target Price
- DOLE $16.67
- VRDN $38.50
- AVG Volume (30 Days)
- DOLE 624.6K
- VRDN 735.2K
- Earning Date
- DOLE 08-13-2025
- VRDN 08-07-2025
- Dividend Yield
- DOLE 2.39%
- VRDN N/A
- EPS Growth
- DOLE N/A
- VRDN N/A
- EPS
- DOLE 0.99
- VRDN N/A
- Revenue
- DOLE $8,453,373,000.00
- VRDN $302,000.00
- Revenue This Year
- DOLE $3.87
- VRDN N/A
- Revenue Next Year
- DOLE $1.93
- VRDN $17,102.33
- P/E Ratio
- DOLE $14.34
- VRDN N/A
- Revenue Growth
- DOLE 0.91
- VRDN 4.86
- 52 Week Low
- DOLE $12.14
- VRDN $9.90
- 52 Week High
- DOLE $17.12
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- DOLE 51.63
- VRDN 45.09
- Support Level
- DOLE $13.62
- VRDN $14.11
- Resistance Level
- DOLE $14.25
- VRDN $14.85
- Average True Range (ATR)
- DOLE 0.28
- VRDN 0.73
- MACD
- DOLE 0.02
- VRDN -0.19
- Stochastic Oscillator
- DOLE 69.23
- VRDN 10.41
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).